Lung cancer remains the most frequently diagnosed cancer globally, with 2.5 million new cases, representing 12.4% of all ...

The lung cancer survival rate has improved 26% in the last five years, according to the American Lung Association’s ...

When Ed O. went to the ER for shortness of breath and trembling, he never imagined he’d receive a diagnosis of unresectable ...

Barbara Rodriguez, 53, later discovered her cancer wasn’t even caused by her smoking, but rather a gene mutation.

Genprex has entered an exclusive licensing agreement with the US University of Michigan for lung cancer therapy, Reqorsa.

Chemotherapy targets cancer cells by disrupting DNA replication and mitotic processes, despite side effects on healthy cells.

Louisiana residents have one of the highest lung cancer death rates in the country, even as groundbreaking treatments in ...

In observance of Lung Cancer Awareness Month, seven medical societies and patient advocacy groups collaborated to raise awareness and advocate for multidisciplinary care in lung cancer treatment. Lung ...

The delivery of nanomedicines using gas bubbles has shown itself to be a unique way of transporting cytotoxins to the lungs of cancer patients. The method enables precise and focused treatments, and ...

A chemotherapy-free regimen of neoadjuvant nivolumab (Opdivo) with or without ipilimumab (Yervoy) induced immune activation ...

metastatic small cell lung cancer and metastatic bladder cancer. Patients with mNSCLC must have received one or two prior lines of platinum-based chemotherapy, a checkpoint inhibitor or both. Patients ...

SINTEF has also signed a licence agreement with a pharmaceutical company. We're very confident that this approach may offer us a new cure for lung cancer." It was in many ways something of a ...